|
2022
|
Invention
|
Immunoglobulin expression levels as biomarker for proteasome inhibitor response.
Methods of trea... |
|
2021
|
Invention
|
Compounds for proteasome enzyme inhibition.
Peptide-based compounds including heteroatom-contain... |
|
2020
|
Invention
|
Tripeptide epoxy ketone protease inhibitors. Provided herein are tripeptide epoxy ketone protease... |
|
|
Invention
|
Combination therapy with peptide epoxyketones.
The invention provides combination therapy, where... |
|
2019
|
Invention
|
Compounds for proteasome.
Peptide-based compounds including heteroatom-containing, three-membere... |
|
|
Invention
|
Peptide epoxyketone proteasome inhibitors in combination with pim kinase inhibitors for treatment... |
|
2018
|
Invention
|
Prodrugs of peptide epoxy ketone protease inhibitors. This disclosure features compounds that are... |
|
2017
|
Invention
|
Combination therapy with peptide epoxyketones. ABSTRACT The invention provides combination therap... |
|
|
Invention
|
Peptide epoxyketone immunoproteasome inhibitors. Provided herein are tripeptide epoxy ketone prot... |
|
|
Invention
|
Compounds for enzyme inhibition. Peptide-based compounds including heteroatom-containing, three-m... |
|
2016
|
Invention
|
Combination therapy with peptide epoxyketones. The invention provides combination therapy, wherei... |
|
|
Invention
|
Modified release formulations for oprozomib.
This disclosure features modified release pharmaceu... |
|
2015
|
Invention
|
Compunds for enzyme inhibition.
Peptide-based compounds including heteroatom-containing, three-m... |
|
|
Invention
|
Crystalline tripeptide epoxy ketone protease inhibitors. The invention relates to crystalline tri... |
|
|
Invention
|
Compounds for enzyme inhibition. One aspect of the invention relates to inhibitors that preferent... |
|
2014
|
Invention
|
Use of peptide epoxyketones for metastasis suppression.
The invention provides a method of repre... |
|
|
Invention
|
Immunoglobulin expression levels as biomarker for proteasome inhibitor response. Methods of treat... |
|
|
Invention
|
Dipeptide and tripeptide epoxy ketone protease inhibitors. Provided herein are dipeptide and trip... |
|
2013
|
Invention
|
Compounds for enzyme inhibition.
One aspect of the invention relates to inhibitors that preferen... |
|
|
Invention
|
Modified release formulations for oprozomib. This disclosure features modified release pharmaceut... |
|
|
Invention
|
Liposomal compositions of epoxyketone-based proteasome inhibitors.
Liposomal compositions compri... |
|
|
Invention
|
Liposomal compositions of epoxyketone-based proteasome inhibitors. Liposomal compositions compris... |
|
|
Invention
|
Prodrugs of peptide epoxy ketone protease inhibitors.
This disclosure features compounds that ar... |
|
|
Invention
|
Prodrugs of peptide epoxy ketone protease inhibitors. Provided herein are compounds of formula (I... |
|
|
Invention
|
Cyclodextrin complexation methods for formulating peptide proteasome inhibitors. This disclosure ... |
